Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Lung/Thoracic Oncology

The prevalence of programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer in an unselected, consecutive population

Modern Pathology | Aug 08, 2019 Lung/Thoracic Oncology

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: Results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

The Lancet Oncology | Aug 07, 2019 Lung/Thoracic Oncology

Pemetrexed, bevacizumab, or the combination as maintenance therapy for advanced nonsquamous non–small-cell lung cancer: ECOG-ACRIN 5508

Journal of Clinical Oncology | Aug 06, 2019 Lung/Thoracic Oncology

Molecular characterization of localized pleural mesothelioma

Modern Pathology | Aug 06, 2019 Lung/Thoracic Oncology

Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis

Journal of the American Academy of Dermatology | Aug 04, 2019 Lung/Thoracic Oncology

End-of-life care in individuals with respiratory diseases: A population study comparing the dying experience between those with chronic obstructive pulmonary disease and lung cancer

International Journal of COPD | Aug 04, 2019 Lung/Thoracic Oncology

Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010-2016 in Sweden: A nationwide observational study

International Journal of Cancer | Aug 02, 2019 Lung/Thoracic Oncology

A multi-center, phase 2 trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

Cancer Management and Research | Aug 02, 2019 Lung/Thoracic Oncology

Cardiorespiratory fitness and incident lung and colorectal cancer in men and women: Results from the Henry Ford Exercise Testing (FIT) cohort

Cancer | Aug 01, 2019 Lung/Thoracic Oncology

Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014

Cancer | Aug 01, 2019 Lung/Thoracic Oncology

« Prev 1 … 77 78 79 80 81 … 149 Next »

The prevalence of programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer in an unselected, consecutive population

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: Results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

Pemetrexed, bevacizumab, or the combination as maintenance therapy for advanced nonsquamous non–small-cell lung cancer: ECOG-ACRIN 5508

Molecular characterization of localized pleural mesothelioma

Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis

End-of-life care in individuals with respiratory diseases: A population study comparing the dying experience between those with chronic obstructive pulmonary disease and lung cancer

Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010-2016 in Sweden: A nationwide observational study

A multi-center, phase 2 trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

Cardiorespiratory fitness and incident lung and colorectal cancer in men and women: Results from the Henry Ford Exercise Testing (FIT) cohort

Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014

BRI or BMI: What is More Efficient?

Awareness for COPD: MCQ challenge

Gut Health Disorders and its Management

How 2 Common Sleep Habits Increase Your Risk of Death

The Role of Exercise and Movement Therapy in Enhancing Recovery from Chronic Conditions

The prevalence of programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer in an unselected, consecutive population

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: Results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

Pemetrexed, bevacizumab, or the combination as maintenance therapy for advanced nonsquamous non–small-cell lung cancer: ECOG-ACRIN 5508

Molecular characterization of localized pleural mesothelioma

Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis

End-of-life care in individuals with respiratory diseases: A population study comparing the dying experience between those with chronic obstructive pulmonary disease and lung cancer

Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010-2016 in Sweden: A nationwide observational study

A multi-center, phase 2 trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

Cardiorespiratory fitness and incident lung and colorectal cancer in men and women: Results from the Henry Ford Exercise Testing (FIT) cohort

Cancer-attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014

BRI or BMI: What is More Efficient?

Awareness for COPD: MCQ challenge

Gut Health Disorders and its Management

How 2 Common Sleep Habits Increase Your Risk of Death

The Role of Exercise and Movement Therapy in Enhancing Recovery from Chronic Conditions

Select Specialty

Select Topic